دورية أكاديمية

72 weeks post-partum follow-up of dolutegravir versus efavirenz initiated in late pregnancy (DolPHIN-2): an open-label, randomised controlled study

التفاصيل البيبلوغرافية
العنوان: 72 weeks post-partum follow-up of dolutegravir versus efavirenz initiated in late pregnancy (DolPHIN-2): an open-label, randomised controlled study
المؤلفون: Boffito, Marta, Clayden, Polly, Peto, Tim, Pozniak, Anton, Taylor, Graham, Kambugu, Andrew, Ayabo, Tabitha, Kitaka, Sabrina Bakeera, Byakika-Kibwika, Pauline, Kiiza, Daniel, Kyohairwe, Isabella, Laker, Eva, Luswata, Andrew, Magoola, Johnson, Mayanja, Hamza, Najujuma, Flavia Vivian, Nakijoba, Ritah, Namuddu, Diana, Namuli, Teopista, Ntuyo, Peter, Onzia, Annet, Sempijja, Emmanuel, Tabwenda, Jovia, William, Baluku, Abrahams, Nina, Magano, Phakamani, Delport, Carmen, Hlwaya, Linda, Mehta, Ushma, Molitsane, Dineo, Odayar, Jasantha, Tambula, Sivuyile, Tyam, Mbuviswa, Venfolo, Olga, Allerton, Joanna, Nkonyana, Thozama, Mqaba, Sibongile, Else, Laura, Potter, Steve, Neary, Anne, Malaba, Thokozile R, Nakatudde, Irene, Kintu, Kenneth, Colbers, Angela, Chen, Tao, Reynolds, Helen, Read, Lucy, Read, Jim, Stemmet, Lee-Ann, Mrubata, Megan, Byrne, Kelly, Seden, Kay, Twimukye, Adelline, Theunissen, Helene, Hodel, Eva Maria, Chiong, Justin, Hu, Nai-Chung, Burger, David, Wang, Duolao, Byamugisha, Josaphat, Alhassan, Yussif, Bokako, Sharon, Waitt, Catriona, Taegtmeyer, Miriam, Orrell, Catherine, Lamorde, Mohammed, Myer, Landon, Khoo, Saye *
المصدر: In The Lancet HIV August 2022 9(8):e534-e543
قاعدة البيانات: ScienceDirect
الوصف
تدمد:23523018
DOI:10.1016/S2352-3018(22)00173-4